Net Medical Xpress Solutions, Inc. (NMXS) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNet Medical Xpress Solutions, Inc. (NMXS) trades at $0.0007. Net Medical Xpress Solutions, Inc. provides telemedicine solutions to various medical facilities, offering services like teleneurology and telecardiology. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for NMXS: NMXS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NMXS against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 29 months old (Mar 31, 2024), so the figures and score below describe that period, not today.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
NMXS: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Net Medical Xpress Solutions, Inc. (NMXS) Healthcare & Pipeline Overview
Net Medical Xpress Solutions, Inc. delivers telemedicine solutions, including its Telemed platform, to hospitals and nursing homes, specializing in areas like teleneurology and telecardiology. Operating in the healthcare information services sector, the company integrates with existing EMR systems to enhance remote patient care and physician support.
What Is the Investment Thesis for NMXS?
Net Medical Xpress Solutions, Inc. operates in the growing telemedicine market, but its financial performance raises concerns. With a negative profit margin of -311.1% and a negative gross margin of -10.1%, the company's profitability is a significant challenge. The company's Telemed platform and integration services could drive future growth, but the current financial metrics suggest a need for improved operational efficiency and revenue generation. The company's small size (23 employees) and OTC listing add to the risk profile. Investors should closely monitor the company's ability to improve its financial performance and capitalize on the telemedicine market's growth potential.
Based on FMP financials and quantitative analysis
NMXS Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- P/E Ratio of -0.01 suggests the company is not currently profitable.
- Profit Margin of -311.1% reflects significant losses relative to revenue.
- Gross Margin of -10.1% indicates that the company's cost of goods sold exceeds its revenue.
- Beta of -1.85 suggests the stock price moves inversely to the market, and with greater volatility.
Who Are NMXS's Competitors?
NMXS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MGRX Mangoceuticals, Inc. | $0.39 | +1.51% | $6.63M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.48 | -1.98% | $8.82M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.35 | -2.69% | $14.1M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | — |
| ONMD OneMedNet Corporation | $0.67 | -1.84% | $38.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NMXS's Key Strengths?
Specialized telemedicine services in areas like teleneurology and telecardiology.
- Proprietary Telemed platform offering customizable telemedicine management.
- Integration capabilities with approximately 43 hospital-based EMR systems.
- Offers a range of services including staffing, recruiting, and diagnostic services.
What Are NMXS's Weaknesses?
Negative profit margin and gross margin indicate financial instability.
- Small market capitalization limits access to capital.
- Limited number of employees (23) may constrain growth potential.
- OTC listing increases risk and reduces liquidity.
What Could Drive NMXS Stock Higher?
Expansion of telemedicine services into new medical specialties.
- Strategic partnerships with hospitals and healthcare systems.
- Development of remote patient monitoring solutions.
- Potential integration of AI and machine learning into the Telemed platform.
- Geographic expansion into international markets.
What Are the Key Risks for NMXS?
Financial-distress signal — its Altman Z-Score of -45.39 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin and gross margin indicate financial instability.
- Small market capitalization limits access to capital.
- Intense competition from established telemedicine providers.
- Evolving regulatory landscape for telemedicine.
- Cybersecurity risks associated with remote healthcare delivery.
What Are the Growth Opportunities for NMXS?
- Expansion of Telemedicine Services: The telemedicine market is experiencing substantial growth, driven by increased demand for remote patient monitoring and virtual consultations. Net Medical Xpress Solutions can capitalize on this trend by expanding its Telemed platform's capabilities and targeting new medical specialties. By offering specialized telemedicine solutions for areas like dermatology or mental health, the company can attract new clients and increase revenue streams. The global telemedicine market is projected to reach $460 billion by 2030, presenting a significant opportunity for growth.
- Strategic Partnerships with Hospitals and Healthcare Systems: Collaborating with hospitals and healthcare systems can provide Net Medical Xpress Solutions with access to a broader patient base and established referral networks. By integrating its Telemed platform with existing hospital EMR systems, the company can streamline workflows and improve patient care coordination. These partnerships can also lead to long-term contracts and recurring revenue streams. Focus on hospitals in rural areas or with limited access to specialists could be a particularly effective strategy.
- Development of Remote Patient Monitoring Solutions: Remote patient monitoring (RPM) is a rapidly growing segment of the telemedicine market, enabling healthcare providers to track patients' vital signs and health data remotely. Net Medical Xpress Solutions can develop and offer RPM solutions that integrate with its Telemed platform, allowing for real-time monitoring and proactive intervention. This can improve patient outcomes, reduce hospital readmissions, and generate additional revenue. The RPM market is projected to reach $178.5 billion by 2027.
- Geographic Expansion: Net Medical Xpress Solutions currently focuses on the US market. Expanding into international markets, particularly in regions with limited access to healthcare, can provide significant growth opportunities. Adapting the Telemed platform to meet the specific needs and regulatory requirements of different countries will be crucial for success. Focusing on countries with government initiatives to promote telemedicine adoption could be a strategic approach.
- Integration of Artificial Intelligence (AI) and Machine Learning (ML): Incorporating AI and ML technologies into the Telemed platform can enhance its capabilities and improve patient outcomes. AI-powered diagnostic tools, personalized treatment recommendations, and automated administrative tasks can streamline workflows and reduce costs. By leveraging AI and ML, Net Medical Xpress Solutions can differentiate itself from competitors and attract clients seeking innovative telemedicine solutions. The AI in healthcare market is projected to reach $95 billion by 2030.
What Are NMXS's Competitive Advantages?
- Proprietary Telemed Platform: The Telemed platform provides a customizable telemedicine management system.
- Integration Capabilities: Integration with approximately 43 hospital-based EMR systems creates switching costs for customers.
- Specialized Telemedicine Services: Focus on specific areas like teleneurology and telecardiology provides expertise and differentiation.
- FDA-Cleared Image Viewers: FDA clearance provides a level of credibility and regulatory compliance.
What Does NMXS Do?
Founded in 1995 and based in Albuquerque, New Mexico, Net Medical Xpress Solutions, Inc., formerly known as New Mexico Software, Inc., has evolved into a telemedicine solutions provider. The company's core offering is its Telemed platform, a customizable telemedicine management system designed for hospitals, nursing homes, specialty hospitals, and other medical facilities. This platform supports a range of services, including teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology. Net Medical Xpress Solutions provides a suite of tools and services, including digital paper, a development engine, single pane of glass software, and FDA-cleared image viewers. The company emphasizes integration, offering connectivity with approximately 43 hospital-based EMR systems. Beyond its technology platform, Net Medical Xpress Solutions provides physicians, administrative services (credentialing, program management, and call center management), and integration services such as electronic prescription software, prior authorization software, laboratory services, malpractice insurance, large-scale provider scheduling, medical translation, and rounding services. Additionally, the company offers staffing and recruiting services, diagnostic and clinical services, and Amazon cloud services. Net Medical Xpress Solutions aims to provide a comprehensive telemedicine solution, addressing both the technological and operational aspects of remote healthcare delivery.
What Products and Services Does NMXS Offer?
- Provides a Telemed telemedicine platform for customized telemedicine management.
- Offers teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology services.
- Develops digital paper, development engine, and single pane of glass software.
- Offers FDA-cleared image viewers.
- Integrates with approximately 43 hospital-based EMR systems.
- Provides telemedicine video conferencing equipment and USB clinical tools.
- Offers administrative services, such as credentialing, program management, and call center management.
How Does NMXS Make Money?
- Software as a Service (SaaS): Charges subscription fees for access to the Telemed platform.
- Service Fees: Generates revenue from providing telemedicine services, such as teleneurology and telecardiology.
- Integration Services: Earns revenue from integrating the Telemed platform with hospital EMR systems and other healthcare IT solutions.
- Staffing and Recruiting: Offers staffing and recruiting services for medical professionals.
What Industry Does NMXS Operate In?
Net Medical Xpress Solutions operates within the healthcare information services industry, a sector experiencing growth due to increasing demand for remote patient monitoring and telehealth solutions. The telemedicine market is projected to continue expanding as healthcare providers seek to improve access, reduce costs, and enhance patient outcomes. However, the industry is competitive, with established players and emerging startups vying for market share. Net Medical Xpress Solutions faces competition from companies like BBLNF (BioAdaptives, Inc.), CVHIF (CareView Communications, Inc.), CYPS (Cypsa), EMGE (Emageon), and LCDX (Lucidia Health), each offering various telemedicine solutions and services.
Who Are NMXS's Key Customers?
- Nursing Homes
- Specialty Hospitals
- Other Medical Facilities
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 894 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 39 |
| 2026-08-26 | 39 |
| 2026-08-29 | 39 |
| 2026-09-01 | 39 |
| 2026-09-04 | 39 |
| 2026-09-07 | 39 |
| 2026-09-10 | 39 |
What changed?
The score has stayed at 39.
Over the same 18 days the stock moved +0.0%.
Company Profile
Net Medical Xpress Solutions, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Albuquerque, US. The company is led by CEO Teresa Dickey. NMXS has traded publicly since 2000.
Financial Health
Net Medical Xpress Solutions, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -45.39 places it in the distress zone, a signal of elevated financial risk.
NMXS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized telemedicine services in areas like teleneurology and telecardiology.
- Proprietary Telemed platform offering customizable telemedicine management.
- Integration capabilities with approximately 43 hospital-based EMR systems.
- Offers a range of services including staffing, recruiting, and diagnostic services.
Bear Case
- Negative profit margin and gross margin indicate financial instability.
- Small market capitalization limits access to capital.
- Limited number of employees (23) may constrain growth potential.
- OTC listing increases risk and reduces liquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2024 | $3,000 | -$202,000 | -$0.01 |
Q1 FY2024 · filed 31 Mar 2024 · SEC EDGAR →
Based on FMP financials and quantitative analysis
NMXS Latest News
No recent news available for NMXS.
NMXS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NMXS.
Price Targets
Wall Street price target analysis for NMXS.
NMXS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NMXS; grades run from A+ (80-100) to F (below 30).
Leadership: Teresa Dickey
CEO
Teresa Dickey serves as the CEO of Net Medical Xpress Solutions, Inc. Her background includes extensive experience in managing and growing technology-driven companies. She has a proven track record in strategic planning, business development, and operational management. Her leadership is focused on driving innovation and expanding the company's reach in the telemedicine market. She is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Track Record: Under Teresa Dickey's leadership, Net Medical Xpress Solutions has focused on expanding its Telemed platform and integrating it with various hospital EMR systems. She has also overseen the development of new telemedicine services and the expansion into new geographic markets. Her strategic decisions have aimed to position the company as a leading provider of telemedicine solutions. She manages 23 employees.
NMXS OTC Market Information
The OTC Other tier, also known as the Pink Market, represents the lowest tier of over-the-counter (OTC) stocks. Companies in this tier often have limited or no financial reporting requirements, making it difficult for investors to assess their financial health and operational performance. Listing on the OTC Other tier is typically associated with higher risk compared to stocks listed on major exchanges like the NYSE or NASDAQ, due to the lack of regulatory oversight and transparency. These companies may be early-stage ventures, financially distressed entities, or foreign companies with limited US presence.
- OTC Tier: OTC Other
- Limited Financial Disclosure: Lack of regular financial reporting increases the difficulty of assessing the company's financial health.
- Low Liquidity: Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Increased Volatility: OTC stocks are generally more volatile than those listed on major exchanges.
- Potential for Fraud or Manipulation: The lack of regulatory oversight increases the risk of fraudulent or manipulative activities.
- Going Concern Risk: Companies on the OTC Other tier may be facing financial difficulties and have a higher risk of going out of business.
- Verify the company's registration and legal standing.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Research any past legal or regulatory issues.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- FDA clearance for image viewers suggests regulatory compliance.
- Integration with approximately 43 hospital-based EMR systems indicates market acceptance.
- Presence of a CEO (Teresa Dickey) and a management team.
- Years in business since 1995 suggests some level of operational history.
- Focus on telemedicine, a growing and potentially lucrative market.
NMXS Healthcare Stock FAQ
Is NMXS a good stock?
Stock Expert AI does not rate NMXS buy, sell or hold. Net Medical Xpress Solutions, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What revenue streams does Net Medical Xpress Solutions, Inc. have in healthcare?
Net Medical Xpress Solutions, Inc. generates revenue through several streams within the healthcare sector. The primary revenue stream is derived from subscription fees for its Telemed platform, a customizable telemedicine management system.
What are the key factors to evaluate for NMXS?
Evaluate NMXS on fundamentals, analyst consensus, and risk factors. Net Medical Xpress Solutions, Inc. operates in the growing telemedicine market, but its financial performance raises concerns. Not financial advice.
How frequently does NMXS data refresh on this page?
NMXS's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NMXS's recent stock price performance?
Net Medical Xpress Solutions, Inc. (NMXS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized telemedicine services in areas like teleneurology and telecardiology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NMXS overvalued or undervalued right now?
Net Medical Xpress Solutions, Inc. (NMXS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of NMXS?
Yes, most major brokerages offer fractional shares of Net Medical Xpress Solutions, Inc. (NMXS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NMXS's earnings and financial reports?
Net Medical Xpress Solutions, Inc. (NMXS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for NMXS earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.